Zhitong Finance App News, Sinopharm (000028.SZ) released its 2026 semi-annual performance report. In the first half year, the company achieved operating income of 36.266 billion yuan, down 1.44% year on year; operating profit of 834 million yuan, down 9.94% year on year; total profit of 827 million yuan, down 9.88% year on year; net profit attributable to shareholders of listed companies was 606 million yuan, down 8.97% year on year. The corresponding basic earnings per share fell 9.17% year on year. Revenue and profit showed a narrowing trend compared to the first quarter, weighted average net asset income The rate decreased by 0.49 percent year over year.

Zhitong Finance App News, Sinopharm (000028.SZ) released its 2026 semi-annual performance report. In the first half year, the company achieved operating income of 36.266 billion yuan, down 1.44% year on year; operating profit of 834 million yuan, down 9.94% year on year; total profit of 827 million yuan, down 9.88% year on year; net profit attributable to shareholders of listed companies was 606 million yuan, down 8.97% year on year. The corresponding basic earnings per share fell 9.17% year on year. Revenue and profit showed a narrowing trend compared to the first quarter, weighted average net asset income The rate decreased by 0.49 percent year over year.